Datamonitor OTC Pharmaceuticals in China 2009

:[phone]f:[phone]e:[e-mail]lesHouse108-110FinchleyRoadLondonNW35JJUnitedKingdomt:[phone]f:[phone]e:[e-mail]tor&PolluxPlatzderEinheit160327FrankfurtDeutschlandt:[phone]f:[phone]e:[e-mail]cLevel46,2ParkStreetSydney,NSW2000Australiat:[phone]f:[phone]e:[e-mail]hinaIndustryProfileReferenceCode:0099-0364Publicationdate:December2009ABOUTDATAMONITORAllRightsReserved.Nopartofthispublicationmaybereproduced,storedinaretrievalsystemortransmittedinanyformbyanymeans,electronic,mechanical,photocopying,recordingorotherwise,withoutthepriorpermissionofthepublisher,Datamonitor.Thefactsofthisreportarebelievedtobecorrectatthetimeofpublicationbutcannotbeguaranteed.Pleasenotethatthefindings,conclusionsandrecommendationsthatDatamonitordeliverswillbebasedoninformationgatheredingoodfaithfrombothprimaryandsecondarysources,whoseaccuracywearenotalwaysinapositiontoguarantee.AssuchDatamonitorcanacceptnoliabilitywhateverforactionstakenbasedonanyinformationthatmaysubsequentlyprovetobeincorrect.China-OTCPharmaceuticals©Datamonitor(PublishedDecember2009)Page2ABOUTDATAMONITORDatamonitorisaleadingbusinessinformationcompanyspecializinginindustryanalysis.Throughitsproprietarydatabasesandwealthofexpertise,Datamonitorprovidesclientswithunbiasedexpertanalysisandindepthforecastsforsixindustrysectors:Healthcare,Technology,Automotive,Energy,ConsumerMarkets,andFinancialServices.ThecompanyalsoadvisesclientsontheimpactthatnewtechnologyandeCommercewillhaveontheirbusinesses.DatamonitormaintainsitsheadquartersinLondon,andregionalofficesinNewYork,Frankfurt,andHongKong.Thecompanyservestheworld’slargest5000companies.Datamonitor'spremiumreportsarebasedonprimaryresearchwithindustrypanelsandconsumers.Wegatherinformationonmarketsegmentation,marketgrowthandpricing,competitorsandproducts.Ourexpertstheninterpretthisdatatoproducedetailedforecastsandactionablerecommendations,helpingyoucreatenewbusinessopportunitiesandideas.Ourseriesofcompany,industryandcountryprofilescomplementsourpremiumproducts,providingtop-levelinformationon10,000companies,2,500industriesand50countries.Whiletheydonotcontainthehighlydetailedbreakdownsfoundinpremiumreports,profilesgiveyouthemostimportantqualitativeandquantitativesummaryinformationyouneed-includingpredictionsandforecasts.EXECUTIVESUMMARYChina-OTCPharmaceuticals©Datamonitor(PublishedDecember2009)Page3EXECUTIVESUMMARYMarketValueTheChineseOTCpharmaceuticalsmarketgrewby7.1%in2008toreachavalueof$8.2billion.MarketValueForecastIn2013,theChineseOTCpharmaceuticalsmarketisforecasttohaveavalueof$11.4billion,anincreaseof38.2%since2008.MarketSegmentationISalesoftraditionalmedicinesgenerated31.1%oftheChineseOTCpharmaceuticalsmarket'svalue.MarketSegmentationIIChinagenerates30.7%oftheAsia-PacificOTCpharmaceuticalsmarket'soverallvalue.MarketShareJohnson&Johnsongenerates6.5%oftheChineseOTCpharmaceuticalsmarket'soverallvalue.DistributionPharmaciesanddrugstoresformaleadingdistributionchannelintheChineseOTCpharmaceuticalsmarket,accountingfor67.9%ofthetotalvalue.CONTENTSChina-OTCPharmaceuticals©Datamonitor(PublishedDecember2009)Page4TABLEOFCONTENTSEXECUTIVESUMMARY3CHAPTER1MarketOverview71.1MarketDefinition71.2ResearchHighlights71.3MarketAnalysis8CHAPTER2MarketValue9CHAPTER3MarketSegmentationI10CHAPTER4MarketSegmentationII11CHAPTER5MarketShare12CHAPTER6FiveForcesAnalysis136.1Summary136.2BuyerPower156.3SupplierPower166.4NewEntrants176.5Substitutes196.6Rivalry20CONTENTSChina-OTCPharmaceuticals©Datamonitor(PublishedDecember2009)Page5CHAPTER7LeadingCompanies227.1Johnson&Johnson227.2NovartisAG267.3ChengduRosunAntisepticPharmaceuticalCo.,Ltd29CHAPTER8Distribution30CHAPTER9MarketForecasts319.1MarketValueForecast31CHAPTER10MacroeconomicIndicators32CHAPTER11Appendix3411.1Methodology3411.2IndustryAssociations3511.3RelatedDatamonitorResearch35CONTENTSChina-OTCPharmaceuticals©Datamonitor(PublishedDecember2009)Page6LISTOFTABLESTable1:ChinaOTCPharmaceuticalsMarketValue:$billion,2004-2008........................9Table2:ChinaOTCPharmaceuticalsMarketSegmentationI:%Share,byValue,2008............................................................................................................................10Table3:ChinaOTCPharmaceuticalsMarketSegmentationII:%Share,byValue,2008...........................................................................................................................11Table4:ChinaOTCPharmaceuticalsMarketShare:%Share,byValue,2008.............12Table5:KeyFacts:Johnson&Johnson........................................................................22Table6:KeyFinancials:Johnson&Johnson.................................................................24Table7:KeyFacts:NovartisAG....................................................................................26Table8:KeyFinancials:NovartisAG.....